Page 1763 - Hematology_ Basic Principles and Practice ( PDFDrive )
P. 1763
Chapter 99 Mesenchymal Stromal Cells 1567
20. Ankrum JA, Ong JF, Karp JM: Mesenchymal stem cells: immune evasive, analysis of clinical trials. PLoS ONE 7:e47559, 2012. PMID 23133515.
not immune privileged. Nat Biotechnol 32:252–260, 2014. PMID 4063485008.
24561556. 4284320647. 26. Sensebe L, Tarte K, Galipeau J, et al: Limited acquisition of chromo-
21. Trounson A, McDonald C: Stem Cell Therapies in Clinical Trials: Pro- somal aberrations in human adult mesenchymal stromal cells. Cell Stem
gress and Challenges. Cell Stem Cell 17:11–22, 2015. PMID 26140604. Cell 10:9–10, author reply -1, 2012. PMID 22226349. 8.
438. 27. von Bahr L, Sundberg B, Lonnies L, et al: Long-term complications,
22. Ning H, Yang F, Jiang M, et al: The correlation between co-transplantation immunologic effects, and role of passage for outcome in mesenchymal
of mesenchymal stem cells and higher recurrence rate in hematologic stromal cell therapy. Biol Blood Marrow Transplant 18:557–564, 2012.
malignancy patients: outcome of a pilot clinical study. Leukemia PMID 21820393. 130.
22:593–599, 2008. PMID 18185520. 433. 28. Sipp D, Turner L: Stem cells. U.S. regulation of stem cells as medical
23. Nauta AJ, Westerhuis G, Kruisselbrink AB, et al: Donor-derived products. Science 338:1296–1297, 2012. PMID 23224541. 436.
mesenchymal stem cells are immunogenic in an allogeneic host and 29. Mendicino M, Bailey AM, Wonnacott K, et al: MSC-based product
stimulate donor graft rejection in a nonmyeloablative setting. Blood characterization for clinical trials: an FDA perspective. Cell Stem Cell
108:2114–2120, 2006. PMID 16690970. 1431895546. 14:141–145, 2014. PMID 24506881. 439.
24. de Lima M, McNiece I, Robinson SN, et al: Cord-blood engraftment 30. Dimmeler S, Ding S, Rando TA, et al: Translational strategies and chal-
with ex vivo mesenchymal-cell coculture. N Engl J Med 367:2305–2315, lenges in regenerative medicine. Nat Med 20:814–821, 2014. PMID
2012. PMID 23234514. 205. 25100527. 434.
25. Lalu MM, McIntyre L, Pugliese C, et al: Safety of cell therapy with
mesenchymal stromal cells (SafeCell): a systematic review and meta-
